SCA
KALA icon

Sassicaia Capital Advisers’s KALA BIO KALA Stock Holding History

Sassicaia Capital Advisers’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-240
Closed -$85.1K – 24
2024
Q2 		$85.1K Buy
+240
New +$79.3K 0.34% 19

Other funds holding KALA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Sassicaia Capital Advisers's KALA Position: Q3 2024 in Review

Sassicaia Capital Advisers sold out of KALA BIO (KALA) in Q3 2024, closing a stake of 240 shares — an estimated $85.1K sold.

Sassicaia Capital Advisers first reported a position in KALA in Q2 2024 and held it in 1 quarter. The position peaked at $85.1K in Q2 2024. 22 funds tracked by Wall St. Rank hold KALA as of Q3 2024.

  • Sassicaia Capital Advisers reported no remaining KALA BIO position as of Q3 2024 after selling out during the quarter.
  • Sassicaia Capital Advisers sold 240 KALA BIO shares in Q3 2024, an estimated $85.1K.
  • Sassicaia Capital Advisers first reported a position in KALA BIO in Q2 2024 and held it in 1 quarter.
  • Sassicaia Capital Advisers's KALA BIO position peaked at $85.1K in Q2 2024.
  • 22 funds tracked by Wall St. Rank held KALA BIO as of Q3 2024.

Based on Sassicaia Capital Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.